Get started
444

TAIMED BIOLOGICS INC.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

4147 chart


Full chart

4147 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪22.34 B‬ TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.5 TWD
Net income (FY)
‪−194.81 M‬ TWD
Revenue (FY)
‪491.78 M‬ TWD
Shares float
‪210.52 M‬
Beta (1Y)
0.16

Employees


Employees (FY)
79
Change (1Y)
0
Revenue / Employee (1Y)
‪6.23 M‬ TWD
Net income / Employee (1Y)
‪−2.47 M‬ TWD

About TAIMED BIOLOGICS INC.


Sector
Health Technology
Industry
Biotechnology
CEO
Chin-Ming Chang
Website
taimedbiologics.com
Headquarters
Taipei
Founded
2007
ISIN
TW0004147004
FIGI
BBG000R2VC95
TaiMed Biologics, Inc. engages in the new drug development for human immunodeficiency virus (HIV). Its products include: (1) TMB-355 for the latter part of acquired immune deficiency syndrome (AIDS) medication. (2) TMB-360/365 for anti-AIDS virus. (3) TMB-607 Protease inhibitors for the anti-AIDS virus. The company was founded by David Ho, LanBo Chen and Ing-Wen Tsai on September 4, 2007 and is headquartered in Taipei, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

4147 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4147 is 82.9 TWD — it has increased by 0.24% in the past 24 hours. Watch TAIMED BIOLOGICS INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange TAIMED BIOLOGICS INC. stocks are traded under the ticker 4147.
4147 stock has fallen by −8.69% compared to the previous week, the month change is a 0.61% rise, over the last year TAIMED BIOLOGICS INC. has showed a 1.70% increase.
We've gathered analysts' opinions on TAIMED BIOLOGICS INC. future price: according to them, 4147 price has a max estimate of 182.00 TWD and a min estimate of 81.10 TWD. Watch 4147 chart and read a more detailed TAIMED BIOLOGICS INC. stock forecast: see what analysts think of TAIMED BIOLOGICS INC. and suggest that you do with its stocks.
4147 reached its all-time high on May 3, 2018 with the price of 344.5 TWD, and its all-time low was 1.0 TWD and was reached on Jul 2, 2015. View more price dynamics on 4147 chart.
See other stocks reaching their highest and lowest prices.
4147 stock is 1.71% volatile and has beta coefficient of 0.16. Track TAIMED BIOLOGICS INC. stock price on the chart and check out the list of the most volatile stocks — is TAIMED BIOLOGICS INC. there?
Today TAIMED BIOLOGICS INC. has the market capitalization of ‪22.34 B‬, it has decreased by −7.88% over the last week.
Yes, you can track TAIMED BIOLOGICS INC. financials in yearly and quarterly reports right on TradingView.
TAIMED BIOLOGICS INC. is going to release the next earnings report on Feb 21, 2025. Keep track of upcoming events with our Earnings Calendar.
4147 earnings for the last quarter are −0.17 TWD per share, whereas the estimation was −0.17 TWD resulting in a 2.94% surprise. The estimated earnings for the next quarter are −0.18 TWD per share. See more details about TAIMED BIOLOGICS INC. earnings.
TAIMED BIOLOGICS INC. revenue for the last quarter amounts to ‪142.00 M‬ TWD, despite the estimated figure of ‪141.00 M‬ TWD. In the next quarter, revenue is expected to reach ‪149.00 M‬ TWD.
4147 net income for the last quarter is ‪−37.79 M‬ TWD, while the quarter before that showed ‪−27.53 M‬ TWD of net income which accounts for −37.25% change. Track more TAIMED BIOLOGICS INC. financial stats to get the full picture.
No, 4147 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 79.00 employees. See our rating of the largest employees — is TAIMED BIOLOGICS INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAIMED BIOLOGICS INC. EBITDA is ‪3.87 M‬ TWD, and current EBITDA margin is −2.33%. See more stats in TAIMED BIOLOGICS INC. financial statements.
Like other stocks, 4147 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAIMED BIOLOGICS INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TAIMED BIOLOGICS INC. technincal analysis shows the neutral today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TAIMED BIOLOGICS INC. stock shows the sell signal. See more of TAIMED BIOLOGICS INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.